SANDOZ ADAPALENE / BENZOYL PEROXIDE GEL

Страна: Канада

Язык: английский

Источник: Health Canada

Активный ингредиент:

ADAPALENE; BENZOYL PEROXIDE

Доступна с:

SANDOZ CANADA INCORPORATED

код АТС:

D10AD53

ИНН (Международная Имя):

ADAPALENE, COMBINATIONS

дозировка:

0.1%; 2.5%

Фармацевтическая форма:

GEL

состав:

ADAPALENE 0.1%; BENZOYL PEROXIDE 2.5%

Администрация маршрут:

TOPICAL

Штук в упаковке:

15G/50G

Тип рецепта:

Prescription

Терапевтические области:

KERATOLYTIC AGENTS

Обзор продуктов:

Active ingredient group (AIG) number: 0252888001; AHFS:

Статус Авторизация:

APPROVED

Дата Авторизация:

2019-09-09

Характеристики продукта

_SANDOZ ADAPALENE/BENZOYL PEROXIDE Product Monograph _
_Page 1 of 41_
PRODUCT MONOGRAPH
Pr
SANDOZ ADAPALENE/BENZOYL PEROXIDE
adapalene and benzoyl peroxide topical gel, 0.1%/2.5% w/w
Acne Therapy
SANDOZ CANADA INC.
110 rue de Lauzon
Boucherville, Québec J4B1E6
Date of Preparation:
September 5, 2019
Submission Control No: 230590
_SANDOZ ADAPALENE/BENZOYL PEROXIDE Product Monograph _
_Page 2 of 41_
TABLE OF CONTENTS
PART I: HEALTH PROFESSIONAL INFORMATION
..........................................................3
SUMMARY PRODUCT INFORMATION
........................................................................3
INDICATIONS AND CLINICAL USE
..............................................................................3
CONTRAINDICATIONS
...................................................................................................3
WARNINGS AND PRECAUTIONS
..................................................................................4
ADVERSE REACTIONS
....................................................................................................6
DRUG INTERACTIONS
..................................................................................................12
DOSAGE AND ADMINISTRATION
..............................................................................13
OVERDOSAGE
................................................................................................................13
ACTION AND CLINICAL PHARMACOLOGY
............................................................14
STORAGE AND STABILITY
..........................................................................................17
SPECIAL HANDLING INSTRUCTIONS
.......................................................................17
DOSAGE FORMS, COMPOSITION AND PACKAGING
.............................................17
PART II: SCIENTIFIC INFORMATION
................................................................................18
PHARMACEUTICAL INFORMATION
.........................................................................